Please login to the form below

Not currently logged in
Email:
Password:

Celgene appoints UK inflammation and immunology director

Rob Moore joins from Abbott
celgene Rob-Moore

Celgene has appointed Rob Moore to head its inflammation and immunology business in the UK and Ireland.

Moore joins from AbbVie (formerly Abbott) where he was rhemautology senior business unit manager for the UK.

During his time at Abbott/AbbVie Moore worked across Western Europe and Canada, including two years in Paris as immunology commercial director, dermatology.

He also set up and led the UK sales team in gastroenterology before moving on to create the business unit for dermatology in 2009, wherein he led the launch of the huge-selling anti-inflammatory drug Humira (adalimumab).

Sam Pearce, VP and general manager, Celgene UK and Ireland, said: “We have an opportunity here to offer effective solutions to patients in need, and are confident that Rob has the knowledge and experience to help us deliver these. “

14th March 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics